[HTML][HTML] Non-surgical treatment of hilar cholangiocarcinoma
R Inchingolo, F Acquafredda, V Ferraro… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Cancer of the biliary confluence also known as hilar cholangiocarcinoma (HC) or Klatskin
tumor, is a rare type of neoplastic disease constituting approximately 40%-60% of …
tumor, is a rare type of neoplastic disease constituting approximately 40%-60% of …
[HTML][HTML] Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events …
E Verzoni, G Cartenì, E Cortesi, D Giannarelli… - … for immunotherapy of …, 2019 - Springer
Abstract Background The Italian Renal Cell Cancer Early Access Program was an expanded
access program that allowed access to nivolumab, for patients (pts) with metastatic renal cell …
access program that allowed access to nivolumab, for patients (pts) with metastatic renal cell …
Renal cell carcinoma in children: a clinicopathologic study
P Indolfi, M Terenziani, F Casale, M Carli… - Journal of clinical …, 2003 - ascopubs.org
Purpose: To identify the prognostic factors, treatment, and outcome of children affected by
renal cell carcinoma (RCC). Patients and Methods: The series included 41 patients (18 …
renal cell carcinoma (RCC). Patients and Methods: The series included 41 patients (18 …
[HTML][HTML] Worldwide management of hepatocellular carcinoma during the COVID-19 pandemic
R Inchingolo, F Acquafredda, M Tedeschi… - World Journal of …, 2021 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) pandemic has impacted hospital
organization, with the necessity to quickly react to face the pandemic. The management of …
organization, with the necessity to quickly react to face the pandemic. The management of …
Phase II study of a protracted irinotecan schedule in children with refractory or recurrent soft tissue sarcoma
G Bisogno, R Riccardi, A Ruggiero… - … Journal of the …, 2006 - Wiley Online Library
Abstract BACKGROUND Irinotecan (CPT‐11) is a novel antineoplastic agent that takes
effect by inhibiting topoisomerase I. The Italian Soft Tissue Sarcoma (STS) Committee …
effect by inhibiting topoisomerase I. The Italian Soft Tissue Sarcoma (STS) Committee …
Long‐term results of the first Italian Association of Pediatric Hematology and Oncology protocol for the treatment of pediatric B‐cell non‐Hodgkin lymphoma (AIEOP …
M Pillon, MT Di Tullio, A Garaventa, S Cesaro… - Cancer, 2004 - Wiley Online Library
BACKGROUND Childhood B‐cell lymphomas (B‐NHLs) represent a group of aggressive
malignancies that are amenable to high‐intensity chemotherapy regimens. In 1992, the …
malignancies that are amenable to high‐intensity chemotherapy regimens. In 1992, the …
[CITATION][C] Outcome of children with acute lymphoblastic leukemia following very late relapse
C Rizzari, SP Di Benedetto, S Galimberti, V Conter… - BLOOD, 1996 - iris.uniroma1.it
Outcome of children with acute lymphoblastic leukemia following very late relapse IRIS IRIS
Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano …
Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano …